Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$70.86 - $89.93 $1.2 Million - $1.52 Million
16,921 New
16,921 $1.25 Million
Q2 2023

Jul 27, 2023

BUY
$66.23 - $88.73 $36,823 - $49,333
556 Added 15.57%
4,126 $346,000
Q1 2023

May 01, 2023

BUY
$53.63 - $82.33 $191,459 - $293,918
3,570 New
3,570 $270,000
Q3 2021

Nov 12, 2021

SELL
$25.92 - $34.51 $273,456 - $364,080
-10,550 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$21.63 - $40.07 $228,196 - $422,738
10,550 New
10,550 $350,000
Q4 2020

Feb 24, 2021

SELL
$11.91 - $19.9 $131,295 - $219,377
-11,024 Closed
0 $0
Q3 2020

Dec 11, 2020

SELL
$13.78 - $18.84 $11,299 - $15,448
-820 Reduced 6.92%
11,024 $152,000
Q2 2020

Aug 07, 2020

BUY
$11.66 - $18.26 $138,101 - $216,271
11,844 New
11,844 $212,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $5.07B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.